---
title: "Sars-CoV2 Vaccine Supply Agreement"
ocid: "ocds-b5fd17-e8798680-9480-4062-8fa2-e3183300e1ec"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-e8798680-9480-4062-8fa2-e3183300e1ec"
markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-e8798680-9480-4062-8fa2-e3183300e1ec.md"
json_url: "https://d3tenders.com/contract/ocds-b5fd17-e8798680-9480-4062-8fa2-e3183300e1ec.json"
source: "Contracts Finder"
current_stage: "Award"
buyer: "BUSINESS ENERGY AND INDUSTRIAL STRATEGY"
published: "2020-12-11"
---

# Sars-CoV2 Vaccine Supply Agreement

Buyer: BUSINESS ENERGY AND INDUSTRIAL STRATEGY  
Current stage: Award  
OCID: ocds-b5fd17-e8798680-9480-4062-8fa2-e3183300e1ec

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-e8798680-9480-4062-8fa2-e3183300e1ec)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-e8798680-9480-4062-8fa2-e3183300e1ec.json)

## Summary

The Business Energy and Industrial Strategy is seeking suppliers for the Sars-CoV2 Vaccine Supply Agreement, a procurement process within the pharmaceuticals industry, specifically focused on the supply of vaccines. The procurement method used is a direct approach via a single tender action, and the procurement period concluded on 12 September 2020. The award date was on 13 September 2020, with the contract running from that date until 31 December 2021. The associated contract values are confidential due to commercial sensitivity.

This tender presents substantial growth opportunities for pharmaceutical companies, particularly those involved in vaccine development and supply. Businesses that are well-suited to compete for this contract include large-scale pharmaceutical manufacturers capable of meeting rigorous regulatory and production standards. Given the competitive nature of the vaccine market, companies with innovative solutions and strong negotiation capabilities will be strategically positioned to benefit from potential future collaborations and contracts in this sector.

## Notice

The clinical development of an inactivated whole virus human vaccine candidate known as VAL2001. Note: This notice corrects and supersedes a previous notice (see links section). It does not represent a new arrangement or contract with the supplier. Additional information: Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate cost per dose. This will (i) commercially prejudice the supplier in its ongoing negotiations with other national governments; (ii) commercially prejudice the contracting authority in its ongoing negotiations with other vaccine vendors and (iii) impact fair competition between vaccine vendors . Contract end date is being withheld on grounds that release of the information would be contrary to public interest under Regulation 50(6)(a). The contract end date is variable based on production and delivery of the requirement. There are significant challenges to overcome and the end date may not be a true reflection, setting unrealistic expectation for the public and in the market. This information is also being withheld on due to commercial sensitivity under Regulation 50(6)(b) and (c) as there is significant competition to develop and bring to the market a successful vaccine. Provision of the contract term may provide valuable information to competitors that may impact negotiations or future competition in the market. Sub-contractor details are being withheld on grounds that release of the information would be contrary to public interest under Regulation 50(6)(a). This information is very sensitive given potential for targeting and disruption of the activities at the facilities which would be contrary to public interest as these activities are critical to success and delivery of the requirement.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Contracts Finder |
| Latest notice | https://www.contractsfinder.service.gov.uk/Notice/cd5013be-e8b8-4e57-82bc-d40301e55ab5 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Direct |
| Procurement method details | Single tender action (below threshold) |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 11 Dec 2020 |
| Submission deadline | 12 Sep 2020 |
| Future notice date | Not specified |
| Award date | 12 Sep 2020 |
| Contract period | 12 Sep 2020 - 31 Dec 2021 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £1 |
| Lots value | Not specified |
| Awards value | £1 |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | BUSINESS ENERGY AND INDUSTRIAL STRATEGY |
| Locality | LONDON |
| Post town | South West London |
| Postcode | SW1H 0ET |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI3 Inner London - West |
| ITL 3 | TLI35 Westminster and City of London |
| Local authority | Westminster |
| Electoral ward | St James's |
| Westminster constituency | Cities of London and Westminster |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 2 |
| Supplier names | VALNEVA; VALNEVA AUSTRIA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33651600 - Vaccines

## Release History

- 11 Dec 2020 at 23:58 - Award - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/cd5013be-e8b8-4e57-82bc-d40301e55ab5

## Documents

- https://www.contractsfinder.service.gov.uk/Notice/cd5013be-e8b8-4e57-82bc-d40301e55ab5
  11th December 2020 - Awarded contract notice on Contracts Finder
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/9d49d9f9-ebbd-4146-b08c-d6cab9fa38bb
  SARS-COV2 VACCINE SUPPLY AGREEMENT - [REDACTED]
- https://www.contractsfinder.service.gov.uk/Notice/df465893-e2e5-4c29-8d36-68ab539423e1
  This link refers to the original notice that is corrected and superseded by this notice.

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-e8798680-9480-4062-8fa2-e3183300e1ec. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-e8798680-9480-4062-8fa2-e3183300e1ec.json.